Edina, MNCIK 16000044 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
33 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Axogen Inc | 5.23M | $171.29M | 13.1% | −572.4K | Reduced |
| 2 | Neogenomics Inc | 10.04M | $118.01M | 9.0% | +107.8K | Added |
| 3 | Si-Bone Inc | 5.03M | $99.25M | 7.6% | +3.12M | Added |
| 4 | Palvella Therapeutics Inc Ne |
| 709.1K |
| $74.23M |
| 5.7% |
| +167.6K |
| Added |
| 5 | Centessa Pharmaceuticals PLC | 2.28M | $57.00M | 4.4% | −1.36M | Reduced |
| 6 | Crinetics Pharmaceuticals In | 1.19M | $55.59M | 4.3% | +252.7K | Added |
| 7 | Atricure Inc | 1.18M | $46.50M | 3.6% | +285.1K | Added |
| 8 | Vera Therapeutics Inc | 869.7K | $44.04M | 3.4% | +362.6K | Added |
| 9 | Disc Medicine Inc | 523.2K | $41.54M | 3.2% | +292.0K | Added |
| 10 | Amylyx Pharmaceuticals Inc | 3.36M | $40.53M | 3.1% | −343 | Reduced |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio